Ticker LaunchLondon · AIM · IPO · ABDX
Abingdon Health plc
Abingdon Health plc (ABDX) was admitted to AIM on Dec 15, 2020, raising £22M at 96p per share. Its market capitalization at admission was about £92M. N+1 Singer acted as nominated adviser.
Abingdon Health is a lateral flow diagnostics company providing contract development and manufacturing services to healthcare and other clients worldwide, including its AbC-19 rapid antibody test.
- Type
- IPO
- Market
- AIM
- Ticker (TIDM)
- ABDX
- Admitted
- Dec 15, 2020
- Offer price
- 96p
- Raised
- £22M
- Market cap at admission
- £92M
- Nominated adviser
- N+1 Singer
- Brokers
- N+1 Singer
- Sector
- Biotech & pharma
- Country
- United Kingdom
More on this listing for subscribers
- New money versus sale shares
- ISIN
- Source announcements
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Sources
From company announcements filed with the FCA's National Storage Mechanism. Subscribers see the list of announcements for each listing.
Other London listings around the same time
- Ecofin U.S. Renewables Infrastructure Trust PLCMain Market · Dec 22, 2020
- Schroder BSC Social Impact Trust plcMain Market · Dec 22, 2020
- Bytes Technology Group plcMain Market · Dec 17, 2020
- Tirupati Graphite plcMain Market · Dec 14, 2020
- Intuitive Investments Group plcAIM · Dec 14, 2020
- Downing Renewables & Infrastructure Trust PLCMain Market · Dec 10, 2020